> 数据图表想问下各位网友2025年创新药板块复盘2025-12-22025年创新药板块复盘 2025前三季度美股前15公司的市场、销售及管理费用共计1266.1亿美元，同比-5.8%，市场、销售及管理费用费用率22.9%，同比-3.2pp。美股前15名医药公司销售费用/ 销售费用率-按市值排序数据来源：Wind，西南证券整理58单位：亿美元2022/122023/12市场、销售及管理费用同比费用率市场、销售及管理费用同比费用率2024/12市场、销售及管理费用同比费用率市场、销售及管理费用同比费用率2025/90.4%20.9%23.6%-31.8%-4.3%6.5%5.4%16.7%0.1%4.2%-1.7%0.9%8.1%15.9%12.5%2.8%26.1%41.5%26.3%34.5%27.5%29.6%17.2%34.0%22.6%16.9%37.7%20.6%20.8%17.4%10.6%25.8%215.1192.2128.7119.6125.2142.3195.091.474.0105.0168.261.860.926.311.41,717.1-13.1%4.3%-15.6%18.3%-12.2%6.0%12.8%25.4%14.9%4.6%-3.4%14.1%7.4%24.4%20.3%1.7%25.3%55.6%23.7%39.4%26.8%30.6%33.3%3.9%21.7%17.5%37.4%21.9%22.5%20.1%11.5%21.3%228.7199.8147.5137.9125.7113.2200.293.585.9108.2172.971.060.929.514.61789.46.3%4.0%14.6%15.3%0.4%-20.5%2.6%2.3%16.1%3.0%2.8%14.8%0.0%12.3%28.8%4.2%25.7%49.0%26.2%44.0%24.3%25.6%31.5%3.2%19.1%16.9%35.8%21.2%21.2%20.8%13.3%19.6%169.2144.4101.286.798.194.3132.883.179.678.475.851.039.819.312.71,266.13.1%-0.9%-7.2%-22.5%8.2%-10.8%-7.7%18.0%29.1%-1.5%-43.7%-2.3%-4.9%-11.0%16.5%-5.8%24.3%33.4%22.7%26.8%22.9%23.3%29.5%23.0%17.4%16.1%21.2%19.0%18.5%18.4%14.4%22.9%公司简称强生公司阿斯利康艾伯维葛兰素史克诺华制药赛诺菲-安万特辉瑞制药诺和诺德礼来默克百时美施贵宝安进吉利德科学再生元制药福泰制药247.7184.2152.6101.1142.5134.2172.972.964.4100.4174.154.156.721.29.4美股前15总计1688.4西南证券健康医疗
